Radiation Oncology

Article	Citations
Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review	96
1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment	89
Medical physics challenges in clinical MR-guided radiotherapy	88
Radiotherapy and the gut microbiome: facts and fiction	83
MR-guided proton therapy: a review and a preview	83
Recent advances in radiotherapy of breast cancer	82
Current status and recent advances in reirradiation of glioblastoma	76
Recent advances of PET imaging in clinical radiation oncology	72
Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma	64
Deep convolutional neural networks for automated segmentation of brain metastases trained on clinical data	64
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations	59
Recent advances in Surface Guided Radiation Therapy	57
Radiation-induced kidney toxicity: molecular and cellular pathogenesis	56
Clinical implementation of MRI-based organs-at-risk auto-segmentation with convolutional networks for prostate radiotherapy	56
First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments	43
Deep learning vs. atlas-based models for fast auto-segmentation of the masticatory muscles on head and neck CT images	40
Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review	37
Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial	37
Implementation of deep learning-based auto-segmentation for radiotherapy planning structures: a workflow study at two cancer centers	37
Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma	35
Treatment plan quality during online adaptive re-planning	35
Radiotherapy of oligometastatic prostate cancer: a systematic review	32
Fully automated brain resection cavity delineation for radiation target volume definition in glioblastoma patients using deep learning	32
Clinical feasibility of deep learning-based auto-segmentation of target volumes and organs-at-risk in breast cancer patients after breast-conserving surgery	30
The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy	30

A multi-center analysis of single-fraction versus hypofractionated stereotactic radiosurgery for the treatment of brain metastasis	30
Deep learning method for prediction of patient-specific dose distribution in breast cancer	30
The basis and advances in clinical application of boron neutron capture therapy	28
Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer	28
Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center p	28
Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis	27
Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation	27
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy	27
Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy	26
Interobserver variability in organ at risk delineation in head and neck cancer	26
Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy	25
Current status and recent advances in resection cavity irradiation of brain metastases	25
Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow	24
Stability and reproducibility of 6013 deep inspiration breath-holds in left-sided breast cancer	24
Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles	24
A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer	24
Impact of superparamagnetic iron oxide nanoparticles on in vitro and in vivo radiosensitisation of cancer cells	24
FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?	23
Evaluation of a treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose calculation system	23
Patient positioning and immobilization procedures for hybrid MR-Linac systems	23
Clinical validation of a commercially available deep learning software for synthetic CT generation for brain	23
Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis	23
Atlas-based auto-segmentation for postoperative radiotherapy planning in endometrial and cervical cancers	23
Patterns of recurrence in anal cancer: a detailed analysis	22
Shift in indications for radiotherapy during the COVID-19 pandemic? A review of organ-specific cancer management recommendations from multidisciplinary and surgical expert groups	22
MR-PROTECT: Clinical feasibility of a prostate MRI-only radiotherapy treatment workflow and investigation of acceptance criteria	22
Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility	21
Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate	21
The roles of CC chemokines in response to radiation	21
Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study	21
The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer	21
Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer	20
Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data can enable treatment response prediction in pancreatic cancer	20
Magnetic resonance imaging features of tumor and lymph node to predict clinical outcome in node-positive cervical cancer: a retrospective analysis	20
Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer	20
Radiation induced temporal lobe necrosis in nasopharyngeal cancer patients after radical external beam radiotherapy	20
The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review	20
Generating synthetic CT from low-dose cone-beam CT by using generative adversarial networks for adaptive radiotherapy	20
Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin’s lymphoma involving the mediastinum	20
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database	20
Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer	20
Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: a systematic review and meta-analysis	20
Explainable AI for CNN-based prostate tumor segmentation in multi-parametric MRI correlated to whole mount histopathology	19
Convolutional neural networks for head and neck tumor segmentation on 7-channel multiparametric MRI: a leave-one-out analysis	19
The clonogenic assay: robustness of plating efficiency-based analysis is strongly compromised by cellular cooperation	19
68Ga-DOTATATE PET-CT as a tool for radiation planning and evaluating treatment responses in the clinical management of meningiomas	19
Online adaptive radiotherapy compared to plan selection for rectal cancer: quantifying the benefit	18
Real-time liver tracking algorithm based on LSTM and SVR networks for use in surface-guided radiation therapy	18
Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy	18
MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial	18

Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model	18
Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count	18
The effect of radiotherapy on taste sensation in head and neck cancer patients – a prospective study	18
Whole brain radiotherapy (WBRT) for leptomeningeal metastasis from NSCLC in the era of targeted therapy: a retrospective study	17
Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study	17
A knowledge-based intensity-modulated radiation therapy treatment planning technique for locally advanced nasopharyngeal carcinoma radiotherapy	17
Evaluation of auto-segmentation accuracy of cloud-based artificial intelligence and atlas-based models	17
Evaluation of deep learning-based autosegmentation in breast cancer radiotherapy	17
Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases	17
Radiotherapy for lentigo maligna and lentigo maligna melanoma – a systematic review	17
Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer	17
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer	17
Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures	17
Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma	17
Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer	17
Automated contouring and planning pipeline for hippocampal-avoidant whole-brain radiotherapy	16
A review of radiomics and genomics applications in cancers: the way towards precision medicine	16
Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis	16
Oncometabolites and the response to radiotherapy	16
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer	16
Heart sparing radiotherapy in breast cancer: the importance of baseline cardiac risks	16
The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease	16
Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy	15
Feasibility study: spot-scanning proton arc therapy (SPArc) for left-sided whole breast radiotherapy	15
Efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis	15
Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 “QUAD shot” regimen for incurable head and neck cancer	15
Design and fabrication of a Nano-based neutron shield for fast neutrons from medical linear accelerators in radiation therapy	15
Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer	14
Impact of adjuvant radiotherapy on the survival of women with optimally resected stage III endometrial cancer in the era of modern radiotherapy: a retrospective study	14
MR-guided stereotactic body radiation therapy for primary cardiac sarcomas	14
MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience	14
A novel three-dimensional template combined with MR-guided 125I brachytherapy for recurrent glioblastoma	14
Stereotactic body radiation therapy in the treatment of ovarian cancer	14
A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma	14
Axitinib in combination with radiotherapy for advanced hepatocellular carcinoma: a phase I clinical trial	14
Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients	14
Overlap time is an independent risk factor of radiation pneumonitis for patients treated with simultaneous EGFR-TKI and thoracic radiotherapy	14
Impact of mouse strain and sex when modeling radiation necrosis	14
The feasibility of a dose painting procedure to treat prostate cancer based on mpMR images and hierarchical clustering	13
Sintilimab, stereotactic body radiotherapy and granulocyte–macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter,	13
Technical assessment of the NDI Polaris Vega optical tracking system	13
Accelerated coronary calcium burden in breast cancer patients after radiotherapy: a comparison with age and race matched healthy women	13
Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treat	13
Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions	13
Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer	13
CPAP (Continuous Positive Airway Pressure) is an effective and stable solution for heart sparing radiotherapy of left sided breast cancer	13
Early circulating tumour DNA kinetics measured by ultra-deep next-generation sequencing during radical radiotherapy for non-small cell lung cancer: a feasibility study	13
Thyroid V50 is a risk factor for hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: a retrospective study	13
Myocardial deformation after radiotherapy: a layer-specific and territorial longitudinal strain analysis in a cohort of left-sided breast cancer patients (BACCARAT study)	13
Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies	13
Accuracy of real-time respiratory motion tracking and time delay of gating radiotherapy based on optical surface imaging technique	13
ITV versus mid-ventilation for treatment planning in lung SBRT: a comparison of target coverage and PTV adequacy by using in-treatment 4D cone beam CT	13
Effect of intrafraction adaptation on PTV margins for MRI guided online adaptive radiotherapy for rectal cancer	13
Clinical features, treatment and outcomes in patients with tracheal adenoid cystic carcinoma: a systematic literature review	13
A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDA	13
Radiation-induced senescence: therapeutic opportunities	13
Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer	13
Dosimetric study between a single isocenter dynamic conformal arc therapy technique and Gamma Knife radiosurgery for multiple brain metastases treatment: impact of target volume geometrical characteri	13
Surgical spacer placement for proton radiotherapy in locally advanced pancreatic body and tail cancers: initial clinical results	13
Anatomic change over the course of treatment for non–small cell lung cancer patients and its impact on intensity-modulated radiation therapy and passive-scattering proton therapy deliveries	13
Medical student education through flipped learning and virtual rotations in radiation oncology during the COVID-19 pandemic: a cross sectional research	12
Oligometastatic head and neck cancer: Which patients benefit from radical local treatment of all tumour sites?	12
Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer	12
A dosimetric and radiobiological evaluation of VMAT following mastectomy for patients with left-sided breast cancer	12
Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study	12
Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results	12
Efficacy and safety of CyberKnife radiosurgery in elderly patients with brain metastases: a retrospective clinical evaluation	12
Reliability of ITV approach to varying treatment fraction time: a retrospective analysis based on 2D cine MR images	12
Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group	12
The dosimetric impact of deep learning-based auto-segmentation of organs at risk on nasopharyngeal and rectal cancer	12
Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI	12
Pediatric craniospinal irradiation with a short partial-arc VMAT technique for medulloblastoma tumors in dosimetric comparison	12
Hippocampal changes in inflammasomes, apoptosis, and MEMRI after radiation-induced brain injury in juvenile rats	12
Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study	12
Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma	12
PET/CT of breast cancer regional nodal recurrences: an evaluation of contouring atlases	12
Radiotherapy for nonagenarians: the value of biological versus chronological age	11
Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)	11
Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study	11
Developing an accurate model of spot-scanning treatment delivery time and sequence for a compact superconducting synchrocyclotron proton therapy system	11

Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy	11
Report on planning comparison of VMAT, IMRT and helical tomotherapy for the ESCALOX-trial pre-study	11
Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techn	11
Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy	11
Dosimetric comparison between RapidArc and HyperArc techniques in salvage stereotactic body radiation therapy for recurrent nasopharyngeal carcinoma	11
Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer	11
Simulation CT-based radiomics for prediction of response after neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer	11
A prospective study investigating the efficacy and toxicity of definitive ChemoRadiation and ImmunOtherapy (CRIO) in locally and/or regionally advanced unresectable cutaneous squamous cell carcinoma	11
SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine	11
A clinical study of curative partial breast irradiation for stage I breast cancer using carbon ion radiotherapy	11
Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience	11
Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy	11
The efficacy of positioning stents in preventing Oral complications after head and neck radiotherapy: a systematic literature review	11
Outcome of early stage Merkel carcinoma treated by exclusive radiation: a study of 53 patients	11
COVID-19 and radiation oncology: the experience of a two-phase plan within a single institution in central Italy	11
The dosimetric impact of replacing the TG-43 algorithm by model based dose calculation for liver brachytherapy	10
Radiotherapy in the treatment of aggressive fibromatosis: experience from a single institution	10
Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations	10
Treatment planning comparison of volumetric modulated arc therapy with the trilogy and the Halcyon for bilateral breast cancer	10
Long-term analysis of multimodality treatment outcomes and prognosis of esthesioneuroblastomas: a single center results of 138 patients	10
Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review	10
Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma	10
Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)	10
DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses	10
Investigating the loco-regional control of simultaneous integrated boost intensity-modulated radiotherapy with different radiation fraction sizes for locally advanced non-small-cell lung cancer: clini	10
Simultaneous radiosurgery for multiple brain metastases: technical overview of the UCLA experience	10
High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas: long-term clinical results of a single particle therapy center	10
Novel role of PAF1 in attenuating radiosensitivity in cervical cancer by inhibiting IER5 transcription	10
Radiotherapy modulates tumor cell fate decisions: a review	10
The diagnostic value of quantitative analysis of ASL, DSC-MRI and DKI in the grading of cerebral gliomas: a meta-analysis	10
Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series	10
The decreased mean platelet volume is associated with poor prognosis in patients with oropharyngeal cancer treated with radiotherapy	10
Oncologic outcomes of pre- versus post-operative radiation in Resectable soft tissue sarcoma: a systematic review and meta-analysis	10
Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohort	10
Dosimetric impact of deep learning-based CT auto-segmentation on radiation therapy treatment planning for prostate cancer	10
Clinical implementation of magnetic resonance imaging simulation for radiation oncology planning: 5 year experience	10
Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy	10
106Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma	10
Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer	9
Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study	9
Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection	9
Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial	9
Radiotherapy combined with gefitinib for patients with locally advanced non-small cell lung cancer who are unfit for surgery or concurrent chemoradiotherapy: a phase II clinical trial	9
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clin	9
Long-term outcome after combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) for vertebral tumors	9
Effectiveness and cost-effectiveness analysis of nimotuzumab for the radiotherapy of locoregionally advanced nasopharyngeal carcinoma	9
A meta-analysis of the efficacy and safety of accelerated partial breast irradiation versus whole-breast irradiation for early-stage breast cancer	9
Impact of delays in radiotherapy of head and neck cancer on outcome	9
Multifocal high-grade glioma radiotherapy safety and efficacy	9
Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials	9
Strict bladder filling and rectal emptying during prostate SBRT: Does it make a dosimetric or clinical difference?	9
Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy	9
Geometric and dosimetric impact of 3D generative adversarial network-based metal artifact reduction algorithm on VMAT and IMPT for the head and neck region	9
Transcatheter rectal arterial chemoembolization with oxaliplatin plus S-1 concurrent chemoradiotherapy can improve the pathological remission rate in locally advanced rectal cancer: a comparative stud	9
Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up p	9
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial	9
The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis	9
Optimal radiotherapy for patients with internal mammary lymph node metastasis from breast cancer	9
Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer	9
ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data	9
Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity	9
Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial	9
Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible	9
Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes	9
High dose simultaneous integrated boost for node positive cervical cancer	9
Clinical application of MR-Linac in tumor radiotherapy: a systematic review	9
Late complications of radiosurgery for cerebral arteriovenous malformations: report of 5 cases of chronic encapsulated intracerebral hematomas and review of the literature	8
Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma	8
Online MR evaluation of inter- and intra-fraction uterus motions and bladder volume changes during cervical cancer external beam radiotherapy	8
Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma	8
Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study	8
125I seeds irradiation inhibits tumor growth and induces apoptosis by Ki-67, P21, survivin, livin and caspase-9 expression in lung carcinoma xenografts	8
The efficacy and dosimetry analysis of CT-guided 125I seed implantation assisted with 3D-printing non-co-planar template in locally recurrent rectal cancer	8
Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy	8
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice	8
The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience	8
Factors affecting outcome in frameless non-isocentric stereotactic radiosurgery for trigeminal neuralgia: a multicentric cohort study	8
Efficacy and safety of carbon ion radiotherapy for bone sarcomas: a systematic review and meta-analysis	8
Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study	8
Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis	8
Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma	8
MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients	8
The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR)	8
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)	8
Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI	8
Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma	8
Clinical predictors of pathological good response in locally advanced rectal cancer	8
Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer: a pooled analysis	8
Unplanned hospitalizations in patients with locoregionally advanced head and neck cancer treated with (chemo)radiotherapy with and without prophylactic percutaneous endoscopic gastrostomy	8
Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter,	7
Technical note: factors affecting dose distribution in the overlap region of two-segment total body irradiation by helical tomotherapy	7
Adjuvant therapy for retroperitoneal sarcoma: a meta-analysis	7
Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory	7
Intraoperative radiotherapy with low energy x-rays for primary and recurrent soft-tissue sarcomas	7
Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy	7